By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cerespir 

41 Madison Avenue, 25th Floor

New York  New York  10010   U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Cerespir Obtains New Patent From USPTO Covering The Optimal Synthetic Route For Commercial Manufacture Of CSP-1103 In Late Stage Development To Slow The Progression Of Mild Cognitive Impairment Due To Alzheimer's Disease 7/14/2015 7:21:16 AM
Cerespir Submits Special Protocol Assessment Request To FDA For A Phase III Clinical Trial To Test The Ability Of CSP-1103 To Slow The Progression Of Mild Cognitive Impairment Due To Alzheimer's Disease 7/1/2015 7:17:22 AM
Cerespir Appoints Sophie Egholm As Chief Operating Officer 4/30/2015 7:42:28 AM
Cerespir Appoints Eric Karran, Ph.D., As Chairman Of Its Scientific Advisory Board 1/7/2015 8:00:15 AM
Cerespir Appoints Adrian N. Hobden, Ph.D., As Chairman Of Its Board Of Directors 9/30/2014 8:27:42 AM
Cerespir Announces The Inauguration Of Its Clinical Advisory Board 2/21/2014 8:52:34 AM
Cerespir Announces Chris Griffett Will Serve As Vice President, Regulatory Affairs 1/10/2014 9:03:26 AM
//-->